Global Drug-Coated Balloon Catheter Market Size, Share, Trends, And Forecast, 2026-2033 Revenue To Reach USD 2.3 Billion As PAD Demand And AI-Guided Care Fuel 8.3% CAGR


Date:

(MENAFN- GlobeNewsWire - Nasdaq) Unlock new revenue streams with actionable insights into drug-coated balloon catheter trends, regional opportunities, competitive strategies, and product innovation.

Dublin, Nov. 20, 2026 (GLOBE NEWSWIRE) -- "Drug-Coated Balloon Catheter Market Size, Share & Trends Analysis Report by Type, End Use, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

The global drug-coated balloon catheter market was valued at an estimated USD 1.2 billion in 2025 and is projected to reach USD 2.3 billion by 2033, expanding at a compound annual growth rate of 8.3% from 2026 to 2033. Market growth is being supported by the increasing prevalence of cardiovascular disease, coronary artery disease, and peripheral artery disease, alongside rising demand for minimally invasive vascular interventions.

Drug-coated balloon catheters are gaining wider adoption in interventional cardiology because they support effective revascularization without leaving permanent implants. Their ability to reduce restenosis and improve vessel patency is strengthening clinical use across hospitals, specialty cardiac and vascular centers, and ambulatory surgical centers. Growing physician confidence, favorable clinical outcomes, and broader access to specialized vascular care are expected to reinforce market expansion throughout the forecast period.

According to data published by Oxford Academic in January 2025, the global age-standardized prevalence of cardiovascular disease was estimated at approximately 7,179 cases per 100,000 people. This persistent disease burden is increasing the need for advanced treatment options for vascular narrowing among patients with coronary and peripheral artery disease. As healthcare systems prioritize procedures that minimize recovery time and avoid permanent implants, demand for drug-coated balloon catheter technologies is expected to accelerate.

Peripheral Artery Disease Fuels Market Demand

The increasing prevalence of Peripheral Artery Disease (PAD) is a major growth driver for the drug-coated balloon catheter industry. An article published by the American Limb Preservation Society in July 2025 projected a 220% increase in PAD cases worldwide by 2050, with prevalence expected to rise from 113 million in 2021 to more than 360 million. This substantial expansion in the patient population is expected to create sustained demand for vascular interventions that restore vessel patency and reduce the risk of restenosis.

Drug-coated balloon catheters are widely used in PAD treatment, including procedures involving femoropopliteal artery disease and Below-the-Knee (BTK) lesions. Their increasing clinical relevance, combined with the growing burden of diabetes, aging populations, and related vascular conditions, is creating opportunities for manufacturers and healthcare providers across established and emerging markets.

Technology Advancements Support Clinical Adoption

Advancements in vascular imaging, catheter design, drug-delivery platforms, and AI-enabled procedural guidance are improving treatment precision and supporting physician decision-making. These developments are particularly important for complex coronary lesions, In-Stent Restenosis (ISR), De-novo coronary lesions, and adjunct coronary procedures. Continued innovation involving Paclitaxel, Sirolimus, and other drug types is also contributing to product differentiation and broader treatment applications.

The report evaluates unit volume and revenue trends from 2021 to 2033 and provides market forecasts at the global, regional, and country levels. It examines the following core segments:

  • Type: Coronary DCB and Peripheral DCB
  • Coronary indications: In-Stent Restenosis (ISR), De-novo coronary lesions, and Complex / Adjunct Coronary Lesions
  • Peripheral indications: Femoropopliteal Artery Disease (PAD) and Below-the-Knee (BTK)
  • Drug type: Paclitaxel, Sirolimus, and others
  • End use: Hospitals, Specialty Cardiac/Vascular Centers, and Ambulatory Surgical Centers (ASCs)

Regional Market Coverage

The regional analysis covers North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Country-level assessments include the U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, India, South Korea, Australia, Thailand, Indonesia, Malaysia, Vietnam, Brazil, Argentina, Colombia, Chile, South Africa, Saudi Arabia, UAE, and Kuwait.

North America and Europe remain important markets due to established interventional cardiology infrastructure, high cardiovascular disease prevalence, and access to advanced catheter technologies. Asia Pacific is expected to present significant growth opportunities as healthcare investment rises, diagnostic capabilities improve, and large patient populations gain access to specialized coronary and peripheral vascular procedures.

Strategic Value of the Report

  • Detailed analysis of drug-coated balloon catheter market size, growth, and segment performance
  • Revenue and unit volume forecasts across major regions and countries
  • Assessment of market trends, clinical adoption factors, and future growth drivers
  • Competitive landscape and market presence analysis of key participants
  • Identification of product innovation, investment opportunities, and potential revenue streams
  • Actionable intelligence to support market entry, portfolio planning, and strategic decision-making

The report provides stakeholders with a focused assessment of the competitive environment, emerging technologies, regional opportunities, and evolving treatment demand. Its findings can support manufacturers, investors, healthcare organizations, and other industry participants seeking to strengthen their position in the expanding global drug-coated balloon catheter market.

Key Attributes:

Report Attribute Details
No. of Pages 200
Forecast Period 2025 - 2033
Estimated Market Value (USD) in 2025 $1.2 Billion
Forecasted Market Value (USD) by 2033 $2.3 Billion
Compound Annual Growth Rate 8.3%
Regions Covered Global


Key Topics Covered:
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Scope
1.1.2. Estimates and Forecast Timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.3.5. Details Of Primary Research
1.4. Information Or Data Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Drug-coated Balloon Catheter Market: Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type Outlook
2.2.2. End Use Outlook
2.3. Competitive Insights
Chapter 3. Drug-coated Balloon Catheter Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Market Opportunity Analysis
3.3. Global Drug-coated Balloon Catheter: Market Analysis Tools
3.3.1. Industry Analysis - Porter's Five Force Analysis
3.3.2. PESTLE Analysis
3.4. Country-Level Market Driver Mapping (Coronary DCB)
3.5. Market Entry Attractiveness Assessment (Coronary DCB)
Chapter 4. Drug-coated Balloon Catheter Market Segment Analysis, by Type (Revenue in USD Million; Unit Volume in Thousand Units, 2021-2033)
4.1. Definition and Scope
4.2. Type Market Share Analysis, 2025 & 2033
4.3. Segment Dashboard
4.4. Global Drug-coated Balloon Catheter Market by Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
4.5.1. Coronary DCB
4.5.2. Peripheral DCB
Chapter 5. Drug-coated Balloon Catheter Market Segment Analysis, by End Use 2021-2033 (USD Million)
5.1. Definition and Scope
5.2. End Use Market Share Analysis, 2025 & 2033
5.3. Segment Dashboard
5.4. Global Drug-coated Balloon Catheter Market by End Use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
5.5.1. Hospitals
5.5.2. Cardiac Centers
5.5.3. Others
Chapter 6. Drug-coated Balloon Catheter Market Segment Analysis, by Region, (Revenue in USD Million; Unit Volume in Thousand Units, 2021-2033)
6.1. Regional Market Share Analysis, 2025 & 2033
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Drug-coated Balloon Catheter Market Share by Region, 2025 & 2033:
6.5. North America
6.5.1. North America Drug-coated Balloon Catheter Market, 2021-2033 (USD Million)
6.5.2. U.S.
6.5.3. Canada
6.5.4. Mexico
6.6. Europe
6.6.1. Europe Drug-coated Balloon Catheter Market, 2021 To 2033 (USD Million)
6.6.2. UK
6.6.3. Germany
6.6.4. France
6.6.5. Italy
6.6.6. Spain
6.6.7. Denmark
6.6.8. Sweden
6.6.9. Norway
6.7. Asia-Pacific
6.7.1. China
6.7.2. Japan
6.7.3. India
6.7.4. Australia
6.7.5. South Korea
6.7.6. Thailand
6.7.7. Indonesia
6.7.8. Malaysia
6.7.9. Vietnam
6.8. Latin America
6.8.1. Latin America Drug-coated Balloon Catheter Market, 2021-2033 (USD Million)
6.8.2. Brazil
6.8.3. Argentina
6.8.4. Colombia
6.8.5. Chile
6.9. MEA
6.9.1. MEA Drug-coated Balloon Catheter Market, 2021-2033 (USD Million)
6.9.2. South Africa
6.9.3. Saudi Arabia
6.9.4. UAE
6.9.5. Kuwait
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, by Key Market Participants
7.2. Company Categorization (Key innovators, market leaders, emerging players)
7.3. Company Market Position Analysis, 2025
7.4. Company Market Share Analysis, 2025/2026 (%)
7.5. Company Profiles
7.5.1. Boston Scientific Corporation
7.5.2. Medtronic
7.5.3. B. Braun Se
7.5.4. Concept Medical
7.5.5. Abbott
7.5.6. Koninklijke Philips N.V.
7.5.7. Teleflex Incorporated (Biotronik)
7.5.8. Translumina
7.5.9. Microport Scientific Corporation
7.5.10. Cardionovum Gmbh
7.5.11. Ivascular S.L.U.
7.5.12. Lepu Medical
7.5.13. Meril Life Sciences Pvt. Ltd.
7.5.14. Cordis
7.5.15. Acotec Scientific (Acotec / Acotec Scientific AG)
7.5.16. SMT
List of Tables [106]
List of Figures [111]
Companies Featured

  • Boston Scientific Corporation
  • Medtronic
  • B. Braun SE
  • Concept Medical
  • Abbott
  • Koninklijke Philips N.V.
  • Teleflex Incorporated (BIOTRONIK)
  • Translumina
  • MicroPort Scientific Corporation
  • Cardionovum GmbH
  • iVascular S.L.U.
  • Lepu Medical
  • Meril Life Sciences Pvt. Ltd.
  • Cordis
  • Acotec Scientific (Acotec / Acotec Scientific AG)
  • SMT

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN20112026004107003653ID1111996994


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search